Intellipharmaceutics International Inc.

IPCIF · OTC
Analyze with AI
8/31/2023
5/31/2023
2/28/2023
11/30/2022
Operating Activities
Net Income-$1,889-$54-$356-$875
Dep. & Amort.$41$41$41$52
Deferred Tax$0$0$0-$5
Stock-Based Comp.$0$0$0$0
Change in WC$2,078$120$289$122
Other Non-Cash$12-$17$11$505
Operating Cash Flow$241$90-$14-$196
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$7
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$7
Financing Activities
Debt Repay.
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$393
Financing Cash Flow$0$0$0$200
Forex Effect$0$0$0-$7
Net Chg. in Cash$241$90-$14$4
Supplemental Information
Beg. Cash$159$70$84$80
End Cash$400$159$70$84
Free Cash Flow$241$90-$14-$196